Data as of Mar 07
| +0.69 / +5.31%|
The 8 analysts offering 12-month price forecasts for Solazyme Inc have a median target of 14.25, with a high estimate of 18.00 and a low estimate of 4.00. The median estimate represents a +4.93% increase from the last price of 13.58.
The current consensus among 8 polled investment analysts is to Buy stock in Solazyme Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.